ArticleArthroplasty (London, England)2026
Comparison of transdermal and oral anti-inflammatory drugs on immediate post-operative pain control in total knee arthroplasty: a randomized controlled trial.
Article in Arthroplasty (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOral nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used as multimodal pain-control medications in total knee arthroplasty (TKA), while topical NSAIDs are commonly used for chronic pain conditions. There is limited evidence on whether topical NSAIDs could provide effective pain control after surgery. We compared the efficacy of topical and oral NSAIDs for immediate post-operative pain following TKA.
methodsThis prospective, randomized, non-inferiority trial included 100 patients undergoing primary TKA. Following uniform anesthesia and multimodal pain management, from post-operative day 1 (POD 1) onward, patients were randomly assigned to receive either a transdermal Esflurbiprofen patch (Group A) or oral Celecoxib (Group B) once daily for 14 days. Pain at rest and on motion, functional outcomes, and adverse events were serially evaluated from POD 0 through 6 weeks post-operatively.
resultsThere were 50 patients in both Group A and B, with a mean age of 72 years and a female predominance (over 70%). There were no differences in demographic data. Both groups had significantly lower visual analog scale (VAS) scores at rest and on motion at POD 0, POD 1, POD 2, POD 3, POD 5, POD 14, and the 6th week, with no differences between groups. The timed up-and-go test (TUGT), 5-time sit-to-stand test (5TSST), and 3-min walk test (3MWT) were similarly significantly worse in both groups at POD 14 and improved in the 6th week. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) was similarly improved at POD 3, POD 14, and in the 6th week, without differences. Both groups had no serious adverse events and no changes in creatinine clearance at any follow-up point.
conclusionA multimodal pain control regimen in TKA using a transdermal Esflurbiprofen patch provided immediate post-operative pain control that was non-inferior to oral Celecoxib, with comparable VAS, functional outcomes, and safety profiles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.